Understanding biosimilars, biologics, and the challenges surrounding their regulation and pricing in the pharmaceutical ...

Roche’s U.S. biotech subsidiary Genentech has wiped its website of past diversity reports as the company’s diversity and ...

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

The use of semaglutide (Ozempic) was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in ...

In 1917, Professor Arthur Stoll created Sandoz's pharmaceutical department and research began ... In 2002, the company increased its investment in Roche to just under one-third of Roche's voting ...

Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com. All trademarks used or mentioned in this release are protected by law.

Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

Genentech, a member of the Roche Group (SIX: RO, ROG ... to solve some of the most difficult challenges in neuroscience today. Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ...

Pharma giant UCB is to invest around £1 billion in the UK as part of a second life sciences sector deal with the UK government, with industry names such as Roche and IQVIA also committing to ...